Showing results (1531-1540 of 1,676) with videos related to

Sort By:
Pageof 168
Trials|March 19, 2025
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trialAlexis Ogdie, Soumya M Reddy, Sarah H Gillespie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 26, 2009
FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testingRobin Dawn Clark, John M Graham, Michael J Friez, et al.
American Journal of Medical Genetics. Part A|November 1, 2008
Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 geneJohn M Graham, Jeannie Visootsak, Elisabeth Dykens, et al.
Nature Genetics|March 6, 2007
A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndromeHiba Risheg, John M Graham, Robin D Clark, et al.
Drug Safety|February 2, 2020
An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational DataGerd R Burmester, Jeffrey R Curtis, Huifeng Yun, et al.
Advances in Therapy|August 10, 2022
The Effect of Guselkumab on Work Productivity in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 TrialJeffrey R Curtis, Iain B McInnes, Proton Rahman, et al.
ACR Open Rheumatology|May 2, 2021
Social Distancing, Health Care Disruptions, Telemedicine Use, and Treatment Interruption During the COVID-19 Pandemic in Patients With or Without Autoimmune Rheumatic DiseaseMichael D George, Joshua F Baker, Shubhasree Banerjee, et al.
Molecular Metabolism|July 10, 2019
Phosphatidylserine decarboxylase is critical for the maintenance of skeletal muscle mitochondrial integrity and muscle massAhrathy Selathurai, Greg M Kowalski, Shaun A Mason, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2015
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathyRonald J Hogg, R Curtis Bay, J Charles Jennette, et al.
Oncoimmunology|January 4, 2018
Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor modelsKatherine E Lewis, Mark J Selby, Gregg Masters, et al.
Pageof 168